Arcalyst (rilonacept) — Highmark
Recurrent Pericarditis (RP)
Initial criteria
- age ≥ 12 years
- diagnosis of recurrent pericarditis
- prescribed by or in consultation with a cardiologist or rheumatologist
- experienced at least one episode of acute pericarditis in past 365 days
- experienced therapeutic failure or intolerance to ≥1 of: NSAIDs, systemic corticosteroids, OR colchicine tablets (or contraindication to all)
Reauthorization criteria
- member is tolerating therapy AND has experienced disease improvement OR delayed disease progression